European ADHD in substance use disorders prevalence study.

• Conditions: attention deficit disorder with hyperactivity; verslaving; ADHD; 10009841

• Registration Number: NL-OMON33223
• Lead Sponsor: Arkin (Amsterdam)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 500

Inclusion Criteria

adults who are referred for treatment of addiction
age 18-65
capable of informed consent

Exclusion Criteria

-inability to fill in the screening questionnaire (e.g. due to limited literacy)
- inability to participate due to drug intoxication, serious psychiatric and/or somatic problems. Efforts should be made to include these patients at a later stage in their treatment.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p> * study centres: descriptive characteristics regarding organisation size,<br /><br>referral processes, diagnostic and treatment procedure, allowing a comparison<br /><br>between the centres and their patient populations<br /><br>* participants: demographic data and diagnostic data (SUD; ADHD; bipolar<br /><br>disorder; depression; borderline and antisocial disorder). </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>nvt</p><br>